EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification and Characterisation of Canine Osteosarcoma Biomarkers and Therapeutic Targets

Jorja Jackson-Oxley iD, Aziza A Alibhai, Rachel Thompson iD, Jennifer Lothion-Roy iD, Simone de Brot iD, Mark D Dunning iD, Jennie N Jeyapalan iD, Nigel P Mongan iD, Catrin S Rutland iD

Cancers · 14.01.2026 · 18 (2) · 262

DOI: 10.3390/cancers18020262 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 14.01.2026. Verfasst von Jorja Jackson-Oxley und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Veterinary Medicine and Sciences, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham LE12 5RD, UK. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Grundy Educational Trust Fund, Geoff Butler PhD Scholarship, School of Veterinary Medicine and Science, University of Nottingham.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Osteosarcoma (OSA) is the most common type of bone cancer in canines. Novel therapies are required to prevent the growth, survival, and metastatic progression of this cancer, to increase life expectancy of patients. Immunohistochemical (IHC) studies and RNA sequencing help us gain a deeper understanding into the molecular mechanisms of the disease.

Methods

We previously compared canine OSA tissues with patient matched non-tumour tissues, revealing 442 overexpressed genes within the samples. The present research used IHC staining for four of these genes in OSA tissues: G protein-coupled receptor 64 (GPR64), TOX High Mobility Group Box Family Member 3 (TOX3), Matrix Metallopeptidase 12 (MMP-12), and Forkhead Box F1 (FOXF1). H-scoring was performed to quantitatively assess protein expression and qualitatively contextualise staining locations. Additional analyses addressed whether gender or anatomical location of lesions (axial or appendicular tumours) affected protein expression. cBioPortal was employed to analyse expression and genetic alterations in patients.

Results

GPR64, TOX3, MMP-12, and FOXF1 showed high mRNA expression and genetic alterations in people with OSA. GPR64, TOX3, MMP-12, and FOXF1 were all expressed in canine OSA with novel findings regarding cellular expression. Additionally, differential sex expression was revealed for GPR64 and TOX3. Potential biomarkers or therapeutic targets were identified.

Conclusions

These studies, and subsequent analysis, have provided insights into the molecular mechanisms associated with OSA progression and revealed potential biomarkers for diagnostic and prognostic purposes. A deeper understanding of genetic and protein interactions will support and progress novel pathways towards diagnostic, prognostic, and treatment interventions for OSA in both veterinary and human medicine.

Schlagwörter

Stichwörter der Autor:innen

G protein-coupled receptor 64 (GPR64)TOX high mobility group Box family member 3 (TOX3)forkhead Box F1 (FOXF1)matrix Metallopeptidase 12 (MMP-12)

Autor:innen und Institutionen

  • School of Veterinary Medicine and Sciences, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham LE12 5RD, UK.
  • Biodiscovery Institute, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham NG7 2RD, UK.
  • COMPATH, Institute of Animal Pathology, University of Bern, CH-3012 Bern, Switzerland.
  • Willows Veterinary Centre and Referral Service, Solihull B90 4NH, UK.
  • Department of Pharmacology, Weill Cornell Medicine, New York, NY 10065, USA.

ORCID-Profile: Jorja Jackson-Oxley, Rachel Thompson, Jennifer Lothion-Roy, Simone de Brot, Mark D Dunning, Jennie N Jeyapalan, Nigel P Mongan, Catrin S Rutland

Förderung

  • Grundy Educational Trust Fund
  • Geoff Butler PhD Scholarship
  • School of Veterinary Medicine and Science, University of Nottingham
  • BBSRC doctoral training programme
  • School of Veterinary Medicine

Zitieren

APA

Jackson-Oxley, J., Alibhai, A. A., Thompson, R., Lothion-Roy, J., de Brot, S., Dunning, M. D., Jeyapalan, J. N., Mongan, N. P., & Rutland, C. S. (2026). Identification and Characterisation of Canine Osteosarcoma Biomarkers and Therapeutic Targets. Cancers, 18(2), 262. https://doi.org/10.3390/cancers18020262

Vancouver

Jackson-Oxley J, Alibhai AA, Thompson R, Lothion-Roy J, de Brot S, Dunning MD, et al. Identification and Characterisation of Canine Osteosarcoma Biomarkers and Therapeutic Targets. Cancers. 2026;18(2):262. doi:10.3390/cancers18020262

BibTeX
@article{JacksonOxley2026,
  author = {Jackson-Oxley, Jorja and Alibhai, Aziza A and Thompson, Rachel and Lothion-Roy, Jennifer and de Brot, Simone and Dunning, Mark D and Jeyapalan, Jennie N and Mongan, Nigel P and Rutland, Catrin S},
  title = {Identification and Characterisation of Canine Osteosarcoma Biomarkers and Therapeutic Targets},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {2},
  pages = {262},
  doi = {10.3390/cancers18020262}
}
Kostenlos starten →